{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:54:34Z","timestamp":1783000474403,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India","award":["39:287"],"award-info":[{"award-number":["39:287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12031-020-01654-0","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T15:03:59Z","timestamp":1594652639000},"page":"338-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-3592","authenticated-orcid":false,"given":"Jayantee","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"1654_CR1","doi-asserted-by":"publisher","unstructured":"Albanese A et al. (2013) Dystonia rating scales: critique and recommendations Movement disorders : official journal of the Movement Disorder Society 28:874-883 doi:https:\/\/doi.org\/10.1002\/mds.25579","DOI":"10.1002\/mds.25579"},{"key":"1654_CR2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.4103\/1673-5374.251203","volume":"14","author":"M Alvarez-Cordoba","year":"2019","unstructured":"Alvarez-Cordoba M et al (2019) Precision medicine in pantothenate kinase-associated neurodegeneration. Neural Regen Res 14:1177\u20131185. https:\/\/doi.org\/10.4103\/1673-5374.251203","journal-title":"Neural Regen Res"},{"key":"1654_CR3","doi-asserted-by":"publisher","first-page":"9740","DOI":"10.1523\/JNEUROSCI.2300-09.2009","volume":"29","author":"M Argyelan","year":"2009","unstructured":"Argyelan M et al (2009) Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 29:9740\u20139747. https:\/\/doi.org\/10.1523\/JNEUROSCI.2300-09.2009","journal-title":"J Neurosci"},{"key":"1654_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1212\/01.WNL.0000149764.34953.BF","volume":"64","author":"K Asanuma","year":"2005","unstructured":"Asanuma K et al (2005) Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64:347\u2013349. https:\/\/doi.org\/10.1212\/01.WNL.0000149764.34953.BF","journal-title":"Neurology"},{"key":"1654_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","volume":"4","author":"B Balint","year":"2018","unstructured":"Balint B, Mencacci NE, Valente EM, Pisani A, Rothwell J, Jankovic J, Vidailhet M, Bhatia KP (2018) Dystonia Nature reviews. Disease primers 4:25. https:\/\/doi.org\/10.1038\/s41572-018-0023-6","journal-title":"Disease primers"},{"key":"1654_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"O Bandmann","year":"2015","unstructured":"Bandmann O, Weiss KH, Kaler SG (2015) Wilson\u2019s disease and other neurological copper disorders. The Lancet Neurology 14:103\u2013113. https:\/\/doi.org\/10.1016\/S1474-4422(14)70190-5","journal-title":"The Lancet Neurology"},{"issue":"Pt 4","key":"1654_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/brain\/117.4.859","volume":"117","author":"KP Bhatia","year":"1994","unstructured":"Bhatia KP, Marsden CD (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain J Neurol 117(Pt 4):859\u2013876. https:\/\/doi.org\/10.1093\/brain\/117.4.859","journal-title":"Brain J Neurol"},{"key":"1654_CR8","unstructured":"Brewer GJ (2001) Wilson\u2019s disease: a clinical guide to recognition, diagnosis, and management. Kluwer Academic Publishers, Boston; Dordrecht"},{"key":"1654_CR9","unstructured":"Brooks DJ (1993) PET studies on the early and differential diagnosis of Parkinson\u2019s disease Neurology 43:S6\u201316"},{"key":"1654_CR10","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1212\/01.wnl.0000120541.97467.fe","volume":"62","author":"M Carbon","year":"2004","unstructured":"Carbon M, Su S, Dhawan V, Raymond D, Bressman S, Eidelberg D (2004) Regional metabolism in primary torsion dystonia: effects of penetrance and genotype. Neurology 62:1384\u20131390. https:\/\/doi.org\/10.1212\/01.wnl.0000120541.97467.fe","journal-title":"Neurology"},{"key":"1654_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","volume":"39","author":"A Ciarmiello","year":"2012","unstructured":"Ciarmiello A, Giovacchini G, Orobello S, Bruselli L, Elifani F, Squitieri F (2012) 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging 39:1030\u20131036. https:\/\/doi.org\/10.1007\/s00259-012-2114-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1654_CR12","doi-asserted-by":"publisher","unstructured":"Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T, Dystonia Study G (2003) Rating scales for dystonia: a multicenter assessment Movement disorders : official journal of the Movement Disorder Society 18:303\u2013312 doi:https:\/\/doi.org\/10.1002\/mds.10377","DOI":"10.1002\/mds.10377"},{"key":"1654_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Czlonkowska","year":"2018","unstructured":"Czlonkowska A et al (2018) Wilson disease Nature reviews. Disease primers 4:21. https:\/\/doi.org\/10.1038\/s41572-018-0018-3","journal-title":"Disease primers"},{"key":"1654_CR14","first-page":"1","volume":"41","author":"A Czlonkowska","year":"2007","unstructured":"Czlonkowska A, Tarnacka B, Moller JC, Leinweber B, Bandmann O, Woimant F, Oertel WH (2007) Unified Wilson\u2019s Disease Rating Scale - a proposal for the neurological scoring of Wilson\u2019s disease patients. Neurol Neurochir Pol 41:1\u201312","journal-title":"Neurol Neurochir Pol"},{"key":"1654_CR15","unstructured":"Daroff RB (2016) Bradley\u2019s neurology in clinical practice. Vol. 2 Vol. 2. Elsevier, London"},{"key":"1654_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for Study of L","year":"2012","unstructured":"European Association for Study of L (2012) EASL clinical practice guidelines: Wilson\u2019s disease. J Hepatol 56:671\u2013685. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.007","journal-title":"J Hepatol"},{"key":"1654_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00439-006-0202-5","volume":"120","author":"P Ferenci","year":"2006","unstructured":"Ferenci P (2006) Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 120:151\u2013159. https:\/\/doi.org\/10.1007\/s00439-006-0202-5","journal-title":"Hum Genet"},{"key":"1654_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/B978-0-444-63625-6.00014-8","volume":"142","author":"P Ferenci","year":"2017","unstructured":"Ferenci P (2017) Diagnosis of Wilson disease. Handb Clin Neurol 142:171\u2013180. https:\/\/doi.org\/10.1016\/B978-0-444-63625-6.00014-8","journal-title":"Handb Clin Neurol"},{"key":"1654_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2249.2008.03755.x","volume":"154","author":"MK Goyal","year":"2008","unstructured":"Goyal MK, Sinha S, Patil SA, Jayalekshmy V, Taly AB (2008) Do cytokines have any role in Wilson\u2019s disease? Clin Exp Immunol 154:74\u201379. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03755.x","journal-title":"Clin Exp Immunol"},{"key":"1654_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1212\/wnl.41.2_part_1.272","volume":"41","author":"G Grimm","year":"1991","unstructured":"Grimm G et al (1991) Comparison of functional and structural brain disturbances in Wilson\u2019s disease. Neurology 41:272\u2013276. https:\/\/doi.org\/10.1212\/wnl.41.2_part_1.272","journal-title":"Neurology"},{"key":"1654_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","volume":"9","author":"DR Janero","year":"1990","unstructured":"Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515\u2013540. https:\/\/doi.org\/10.1016\/0891-5849(90)90131-2","journal-title":"Free Radic Biol Med"},{"key":"1654_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000355276","volume":"71","author":"J Kalita","year":"2014","unstructured":"Kalita J, Kumar V, Chandra S, Kumar B, Misra UK (2014a) Worsening of Wilson disease following penicillamine therapy. Eur Neurol 71:126\u2013131. https:\/\/doi.org\/10.1159\/000355276","journal-title":"Eur Neurol"},{"key":"1654_CR23","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1007\/s12035-015-9570-y","volume":"53","author":"J Kalita","year":"2016","unstructured":"Kalita J, Kumar V, Misra UK (2016) A study on apoptosis and anti-apoptotic status in Wilson disease. Mol Neurobiol 53:6659\u20136667. https:\/\/doi.org\/10.1007\/s12035-015-9570-y","journal-title":"Mol Neurobiol"},{"key":"1654_CR24","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1007\/s12035-017-0619-y","volume":"55","author":"J Kalita","year":"2018","unstructured":"Kalita J, Kumar V, Misra UK, Bora HK (2018) Memory and learning dysfunction following copper toxicity: biochemical and immunohistochemical basis. Mol Neurobiol 55:3800\u20133811. https:\/\/doi.org\/10.1007\/s12035-017-0619-y","journal-title":"Mol Neurobiol"},{"key":"1654_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12640-019-00140-9","volume":"37","author":"J Kalita","year":"2020","unstructured":"Kalita J, Kumar V, Misra UK, Bora HK (2020a) Movement disorder in copper toxicity rat model: role of inflammation and apoptosis in the corpus striatum. Neurotox Res 37:904\u2013912. https:\/\/doi.org\/10.1007\/s12640-019-00140-9","journal-title":"Neurotox Res"},{"key":"1654_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12031-019-01423-8","volume":"70","author":"J Kalita","year":"2020","unstructured":"Kalita J, Kumar V, Misra UK, Parashar V, Ranjan A (2020b) Adjunctive antioxidant therapy in neurologic Wilson\u2019s disease improves the outcomes. Journal of molecular neuroscience : MN 70:378\u2013385. https:\/\/doi.org\/10.1007\/s12031-019-01423-8","journal-title":"Journal of molecular neuroscience : MN"},{"key":"1654_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jneuroim.2014.06.013","volume":"274","author":"J Kalita","year":"2014","unstructured":"Kalita J, Kumar V, Misra UK, Ranjan A, Khan H, Konwar R (2014b) A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings. J Neuroimmunol 274:141\u2013148. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.06.013","journal-title":"J Neuroimmunol"},{"key":"1654_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12017-015-8364-8","volume":"17","author":"J Kalita","year":"2015","unstructured":"Kalita J, Kumar V, Ranjan A, Misra UK (2015a) Role of oxidative stress in the worsening of neurologic Wilson disease following chelating therapy. NeuroMolecular Med 17:364\u2013372. https:\/\/doi.org\/10.1007\/s12017-015-8364-8","journal-title":"NeuroMolecular Med"},{"key":"1654_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neuro.2018.12.005","volume":"71","author":"J Kalita","year":"2019","unstructured":"Kalita J, Misra UK, Kumar V, Parashar V (2019) Predictors of seizure in Wilson disease: a clinico-radiological and biomarkers study. Neurotoxicology 71:87\u201392. https:\/\/doi.org\/10.1016\/j.neuro.2018.12.005","journal-title":"Neurotoxicology"},{"key":"1654_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2011.02.001","volume":"304","author":"J Kalita","year":"2011","unstructured":"Kalita J, Misra UK, Pradhan PK (2011) Oromandibular dystonia in encephalitis. J Neurol Sci 304:107\u2013110. https:\/\/doi.org\/10.1016\/j.jns.2011.02.001","journal-title":"J Neurol Sci"},{"key":"1654_CR31","doi-asserted-by":"publisher","unstructured":"Kalita J, Ranjan A, Misra UK (2015b) Oromandibular dystonia in Wilson\u2019s disease movement disorders clinical practice 2:253\u2013259 doi:https:\/\/doi.org\/10.1002\/mdc3.12171","DOI":"10.1002\/mdc3.12171"},{"key":"1654_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jocn.2012.02.041","volume":"20","author":"B Kim","year":"2013","unstructured":"Kim B, Chung SJ, Shin HW (2013) Trientine-induced neurological deterioration in a patient with Wilson\u2019s disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20:606\u2013608. https:\/\/doi.org\/10.1016\/j.jocn.2012.02.041","journal-title":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia"},{"key":"1654_CR33","first-page":"1373","volume":"27","author":"TJ Kim","year":"2006","unstructured":"Kim TJ, Kim IO, Kim WS, Cheon JE, Moon SG, Kwon JW, Seo JK, Yeon KM (2006) MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 27:1373\u20131378","journal-title":"AJNR Am J Neuroradiol"},{"key":"1654_CR34","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2214\/ajr.167.6.8956601","volume":"167","author":"AD King","year":"1996","unstructured":"King AD et al (1996) Cranial MR imaging in Wilson\u2019s disease. AJR Am J Roentgenol 167:1579\u20131584. https:\/\/doi.org\/10.2214\/ajr.167.6.8956601","journal-title":"AJR Am J Roentgenol"},{"key":"1654_CR35","doi-asserted-by":"publisher","unstructured":"Kinghorn KJ et al. (2015) Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction Brain : a journal of neurology 138:1801-1816 doi:https:\/\/doi.org\/10.1093\/brain\/awv132","DOI":"10.1093\/brain\/awv132"},{"key":"1654_CR36","doi-asserted-by":"publisher","unstructured":"Kluska A et al. (2019) Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson\u2019s disease phenotype Liver international : official journal of the International Association for the Study of the Liver 39:177-186 doi:https:\/\/doi.org\/10.1111\/liv.13967","DOI":"10.1111\/liv.13967"},{"key":"1654_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jcp.54.5.356","volume":"54","author":"D Koracevic","year":"2001","unstructured":"Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V (2001) Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54:356\u2013361. https:\/\/doi.org\/10.1136\/jcp.54.5.356","journal-title":"J Clin Pathol"},{"key":"1654_CR38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/mds.21392","volume":"22","author":"P Krystkowiak","year":"2007","unstructured":"Krystkowiak P et al (2007) Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Movement disorders : official journal of the Movement Disorder Society 22:685\u2013689. https:\/\/doi.org\/10.1002\/mds.21392","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"1654_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2015.06.010","volume":"355","author":"T Litwin","year":"2015","unstructured":"Litwin T, Dziezyc K, Karlinski M, Chabik G, Czepiel W, Czlonkowska A (2015) Early neurological worsening in patients with Wilson\u2019s disease. J Neurol Sci 355:162\u2013167. https:\/\/doi.org\/10.1016\/j.jns.2015.06.010","journal-title":"J Neurol Sci"},{"key":"1654_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11011-013-9378-2","volume":"28","author":"T Litwin","year":"2013","unstructured":"Litwin T, Gromadzka G, Czlonkowska A, Golebiowski M, Poniatowska R (2013) The effect of gender on brain MRI pathology in Wilson\u2019s disease. Metab Brain Dis 28:69\u201375. https:\/\/doi.org\/10.1007\/s11011-013-9378-2","journal-title":"Metab Brain Dis"},{"key":"1654_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4329\/wjr.v8.i3.226","volume":"8","author":"KJ Lizarraga","year":"2016","unstructured":"Lizarraga KJ, Gorgulho A, Chen W, De Salles AA (2016) Molecular imaging of movement disorders. World Journal of Radiology 8:226\u2013239. https:\/\/doi.org\/10.4329\/wjr.v8.i3.226","journal-title":"World Journal of Radiology"},{"key":"1654_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/104454902753759681","volume":"21","author":"RM Llanos","year":"2002","unstructured":"Llanos RM, Mercer JF (2002) The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol 21:259\u2013270. https:\/\/doi.org\/10.1089\/104454902753759681","journal-title":"DNA Cell Biol"},{"key":"1654_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05109.x","volume":"1184","author":"MT Lorincz","year":"2010","unstructured":"Lorincz MT (2010) Neurologic Wilson\u2019s disease Annals of the New York. Acad Sci 1184:173\u2013187. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05109.x","journal-title":"Acad Sci"},{"key":"1654_CR44","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21170","volume":"21","author":"A Machado","year":"2006","unstructured":"Machado A, Chien HF, Deguti MM, Cancado E, Azevedo RS, Scaff M, Barbosa ER (2006) Neurological manifestations in Wilson\u2019s disease: report of 119 cases. Movement disorders : official journal of the Movement Disorder Society 21:2192\u20132196. https:\/\/doi.org\/10.1002\/mds.21170","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"1654_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-0-444-63625-6.00006-9","volume":"142","author":"V Medici","year":"2017","unstructured":"Medici V, Huster D (2017) Animal models of Wilson disease. Handb Clin Neurol 142:57\u201370. https:\/\/doi.org\/10.1016\/B978-0-444-63625-6.00006-9","journal-title":"Handb Clin Neurol"},{"key":"1654_CR46","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1007\/s00415-010-5659-4","volume":"257","author":"UK Misra","year":"2010","unstructured":"Misra UK, Kalita J (2010) Spectrum of movement disorders in encephalitis. J Neurol 257:2052\u20132058. https:\/\/doi.org\/10.1007\/s00415-010-5659-4","journal-title":"J Neurol"},{"key":"1654_CR47","doi-asserted-by":"publisher","unstructured":"Musacco-Sebio R et al. (2014) Oxidative damage to rat brain in iron and copper overloads Metallomics : integrated biometal science 6:1410-1416 doi:https:\/\/doi.org\/10.1039\/c3mt00378g","DOI":"10.1039\/c3mt00378g"},{"key":"1654_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0022-510x(85)90135-2","volume":"69","author":"C Nahmias","year":"1985","unstructured":"Nahmias C, Garnett ES, Firnau G, Lang A (1985) Striatal dopamine distribution in parkinsonian patients during life. J Neurol Sci 69:223\u2013230. https:\/\/doi.org\/10.1016\/0022-510x(85)90135-2","journal-title":"J Neurol Sci"},{"key":"1654_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12011-008-8219-3","volume":"127","author":"D Ozcelik","year":"2009","unstructured":"Ozcelik D, Uzun H (2009) Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 127:45\u201352. https:\/\/doi.org\/10.1007\/s12011-008-8219-3","journal-title":"Biol Trace Elem Res"},{"key":"1654_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clineuro.2015.07.013","volume":"138","author":"A Ranjan","year":"2015","unstructured":"Ranjan A, Kalita J, Kumar S, Bhoi SK, Misra UK (2015) A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg 138:31\u201336. https:\/\/doi.org\/10.1016\/j.clineuro.2015.07.013","journal-title":"Clin Neurol Neurosurg"},{"key":"1654_CR51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jnc.14323","volume":"146","author":"E Reed","year":"2018","unstructured":"Reed E, Lutsenko S, Bandmann O (2018) Animal models of Wilson disease. J Neurochem 146:356\u2013373. https:\/\/doi.org\/10.1111\/jnc.14323","journal-title":"J Neurochem"},{"key":"1654_CR52","doi-asserted-by":"publisher","unstructured":"Roberts EA, Schilsky ML, American Association for Study of Liver D (2008) Diagnosis and treatment of Wilson disease: an update Hepatology 47:2089\u20132111 doi:https:\/\/doi.org\/10.1002\/hep.22261","DOI":"10.1002\/hep.22261"},{"key":"1654_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pneurobio.2014.01.002","volume":"116","author":"IF Scheiber","year":"2014","unstructured":"Scheiber IF, Mercer JF, Dringen R (2014) Metabolism and functions of copper in brain. Prog Neurobiol 116:33\u201357. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.01.002","journal-title":"Prog Neurobiol"},{"key":"1654_CR54","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1259\/bjr\/48911350","volume":"80","author":"S Sinha","year":"2007","unstructured":"Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK (2007) Sequential MRI changes in Wilson\u2019s disease with de-coppering therapy: a study of 50 patients. Br J Radiol 80:744\u2013749. https:\/\/doi.org\/10.1259\/bjr\/48911350","journal-title":"Br J Radiol"},{"key":"1654_CR55","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00234-010-0661-1","volume":"52","author":"S Sinha","year":"2010","unstructured":"Sinha S, Taly AB, Ravishankar S, Prashanth LK, Vasudev MK (2010) Wilson\u2019s disease: (31)P and (1)H MR spectroscopy and clinical correlation. Neuroradiology 52:977\u2013985. https:\/\/doi.org\/10.1007\/s00234-010-0661-1","journal-title":"Neuroradiology"},{"key":"1654_CR56","doi-asserted-by":"publisher","unstructured":"Svetel M, Kozic D, Stefanova E, Semnic R, Dragasevic N, Kostic VS (2001) Dystonia in Wilson\u2019s disease Movement disorders : official journal of the Movement Disorder Society 16:719\u2013723 doi:https:\/\/doi.org\/10.1002\/mds.1118","DOI":"10.1002\/mds.1118"},{"key":"1654_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/MD.0b013e318045a00e","volume":"86","author":"AB Taly","year":"2007","unstructured":"Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR (2007) Wilson disease: description of 282 patients evaluated over 3 decades. Medicine 86:112\u2013121. https:\/\/doi.org\/10.1097\/MD.0b013e318045a00e","journal-title":"Medicine"},{"key":"1654_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pneurobio.2018.07.003","volume":"169","author":"N Tambasco","year":"2018","unstructured":"Tambasco N, Romoli M, Calabresi P (2018) Selective basal ganglia vulnerability to energy deprivation: experimental and clinical evidences. Prog Neurobiol 169:55\u201375. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.07.003","journal-title":"Prog Neurobiol"},{"key":"1654_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng0295-210","volume":"9","author":"GR Thomas","year":"1995","unstructured":"Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW (1995) The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 9:210\u2013217. https:\/\/doi.org\/10.1038\/ng0295-210","journal-title":"Nat Genet"},{"key":"1654_CR60","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","volume":"27","author":"F Tietze","year":"1969","unstructured":"Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502\u2013522. https:\/\/doi.org\/10.1016\/0003-2697(69)90064-5","journal-title":"Anal Biochem"},{"key":"1654_CR61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3174\/ajnr.A5936","volume":"40","author":"XE Yu","year":"2019","unstructured":"Yu XE, Gao S, Yang RM, Han YZ (2019) MR imaging of the brain in neurologic Wilson disease. AJNR Am J Neuroradiol 40:178\u2013183. https:\/\/doi.org\/10.3174\/ajnr.A5936","journal-title":"AJNR Am J Neuroradiol"},{"key":"1654_CR62","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1021\/jm00034a006","volume":"37","author":"F Zhang","year":"1994","unstructured":"Zhang F, Dryhurst G (1994) Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson\u2019s disease. J Med Chem 37:1084\u20131098. https:\/\/doi.org\/10.1021\/jm00034a006","journal-title":"J Med Chem"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01654-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:25:44Z","timestamp":1626135944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01654-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01654-0","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Institutional Ethics Committee, SGPGIMS, Lucknow, has approved the research (Ethic No., A-03: PGI\/IMP\/IEC\/56\/19.08.2011). We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}